IFP Advisors’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

IFP Advisors’s Portfolio SIOX Stock Details SIOX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-18	Closed	-$51	–	3284
2020 Q4	$0	Hold	18	–	–	﹤0.01%	3142
2020 Q3	$0	Hold	18	–	–	﹤0.01%	3048
2020 Q2	$0	Hold	18	–	–	﹤0.01%	3013
2020 Q1	$0	Hold	18	–	–	﹤0.01%	3072
2019 Q4	$0	Hold	18	–	–	﹤0.01%	3194
2019 Q3	$0	Buy	+18	New	+$124	﹤0.01%	3166
2019 Q1	–	Sell	-19	Closed	–	–	3629
2018 Q4	$0	Hold	19	–	–	﹤0.01%	3959
2018 Q3	$0	Hold	19	–	–	﹤0.01%	4073
2018 Q2	$0	Hold	19	–	–	﹤0.01%	4115
2018 Q1	$1K	Hold	19	–	–	﹤0.01%	3696
2017 Q4	$1K	Sell	19 -62	-77%	-$2.78K	﹤0.01%	3747
2017 Q3	$4K	Buy	81 +6	+8%	+$1.01K	﹤0.01%	3556
2017 Q2	$14K	Sell	75 -13	-15%	-$2.28K	﹤0.01%	2822
2017 Q1	$10K	Hold	88	–	–	﹤0.01%	2938
2016 Q4	$9K	Buy	88 +63	+252%	+$6.63K	﹤0.01%	2991
2016 Q3	$3K	Hold	25	–	–	﹤0.01%	3496
2016 Q2	$3K	Buy	+25	New	+$2.5K	﹤0.01%	3390
2016 Q1	–	Sell	-25	Closed	-$4K	–	3619
2015 Q4	$4K	Buy	+25	New	+$3.25K	﹤0.01%	3116

Other funds holding SIOX

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

TVWM

Tower View Wealth Management Shorewood, Wisconsin $195M AUM 29.88% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

IFP Advisors's SIOX Position: Q1 2021 in Review

IFP Advisors sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q1 2021, closing a stake of 18 shares — an estimated $51 sold.

IFP Advisors first reported a position in SIOX in Q4 2015 and held it in 18 quarters. The position peaked at $14K in Q2 2017. 56 funds tracked by Wall St. Rank hold SIOX as of Q1 2021.

IFP Advisors reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
IFP Advisors sold 18 Sio Gene Therapies Inc. Common Stock shares in Q1 2021, an estimated $51.
IFP Advisors first reported a position in Sio Gene Therapies Inc. Common Stock in Q4 2015 and held it in 18 quarters.
IFP Advisors's Sio Gene Therapies Inc. Common Stock position peaked at $14K in Q2 2017.
56 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q1 2021.

Based on IFP Advisors's 13F filing for Q1 2021, filed 30 Apr 2021.